Navigation Links
Health Robotics Continues Global Expansion Into Oceania With Device Technologies Australia's Strategic Partnership
Date:9/21/2009

BOZEN, Italy, September 21 /PRNewswire/ -- Health Robotics today announced that it has signed an exclusive five-year strategic partnership with Device Technologies Australia Pty Ltd. for its revolutionary CytoCare(TM) Robot. This strategic agreement enables Device Technologies Australia to achieve its goal of safely, accurately and cost-effectively automating the preparation of Oncology I.V. Admixtures to complement its other market-leading Oncology and Surgery Robotic solutions.

CytoCare is the world's first and only robotic system designed for the safe and sterile preparation of patient-specific hazardous IV Admixtures. While other companies have for many years made promises of robotic IV automation products, and even showcased marketing demonstrations of competing solutions that were supposed to exist as far back twenty years[1] ago, the fact remains that CytoCare is the only available solution that currently exists anywhere in the world to automatically compound and prepare ready-to-administer hazardous IV Admixtures, and that has been proven to work in a "live" hospital pharmacy environment, instead of just marketing brochures and trade-shows demos.

"We are thrilled to have been chosen by Health Robotics as their exclusive CytoCare partner for Oceania. CytoCare, a-one-of-its-kind solution, represents an ideal complement to our market-leading CyberKnife(R) and da Vinci(R) Surgical System robotic solutions. We are very impressed by the introductory work that a small foreign company like Health Robotics has been able to do in both Australia and New Zealand, and are eager to take the "baton" from Health Robotics and continue their work in our core markets, expanding the reach of CytoCare to other hospitals in Oceania", stated Peter Ord, CEO of Device Technologies Australia."

Device Technologies believes that CytoCare has the potential to become the gold standard for Oncology I.V. Admixture
'/>"/>

SOURCE Health Robotics
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Alere Executive Keynote at DMAA Conference Stresses Combining Medical and Health Improvement Models to Bring About Cost-Effective Changes in Healthcare Reform
2. Death Panel Inventor & Critic of Healthcare Reform Betsy McCaughey Has Close Ties to Philip Morris; Healthcare Industry Today Offers Complete Coverage
3. BioCryst Awarded Additional $77.2 Million by the U.S. Department of Health & Human Services To Develop Peramivir for Influenza
4. YourCity.MD's city health directory portals Put Local TV Broadcasters in a Position to Dominate Local Healthcare Revenues, from the Web!
5. Traditional Chinese Medicine and Acupuncture Continue to Grow in Popularity Due to Focus on Natural Health
6. Mens Health Network, The Washington Redskins and GlaxoSmithKline Team Up for Septembers Prostate Cancer Awareness Month
7. Health Plans Reduce Administrative Expenses with HEALTHsuite(R) from RAM Technologies, Inc.
8. New Poll: Americans Still Confused by President Obamas Health Care Plan -- Siegel+Gale Survey Finds Dramatic Lack of Understanding of Basic Points in Plan, Even Among Democrats
9. Statement From Stuart L. Weinstein, MD, Chairman, Doctors for Medical Liability Reform on Senator Baucus Health Care Reform Proposal
10. Back To School and Back To Important Health Basics For Youth
11. Cabot(R) Creamery Cooperatives Vermont-To-Vegas Virtual Challenge Ends On A Healthy Note
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2012)... (May 22, 2012) Pushed to the brink of ... into an ancient system that has helped organisms cope ... As an integral part of this system, heat ... malignant cells accommodate the genetic changes and profound disturbances ... Researchers have theorized that inhibiting HSP90 just might render ...
(Date:5/22/2012)... to quit smoking during pregnancy can significantly improve ... Vitamin C daily, according to a new study ... Hospital. , "Smoking during pregnancy is known to ... baby, causing lifelong decreased lung function and an ... M.C.R., neonatologist and associate professor of pediatrics at ...
(Date:5/22/2012)... TUESDAY, May 22 (HealthDay News) -- The number of ... 2006, a new study finds. Researchers said one ... cardiac death has become more commonplace, and many of ... the organs aren,t healthy enough to attempt a transplant. ... due to a condition known as fatty liver disease, ...
(Date:5/22/2012)... UC Davis have developed a microfluidic chip to test ... cheaper, faster and more reliable than current testing for ... gives results in real time," said Ying Liu, a ... UC Davis Department of Biomedical Engineering. , The team ... in China and the United States. , About one-third ...
(Date:5/22/2012)... have identified novel biomarkers that could be used to ... people potentially exposed to unknown and variable doses for ... are published in the May 1 issue of ... of surgery, biochemistry, pharmacology and toxicology at the Medical ... study. , There is an urgent need for rapid, ...
Breaking Medicine News(10 mins):Health News:Breast cancer clinical trial tests combo of heat shock protein inhibitor and hormonal therapy 2Health News:Breast cancer clinical trial tests combo of heat shock protein inhibitor and hormonal therapy 3Health News:Vitamin C improves lung function in newborns of pregnant smoking women 2Health News:U.S. Liver Transplants Declining 2Health News:New TB test promises to be cheap and fast 2
... the time pancreatic cancer is discovered, it is often late stage ... are low. Dr. Aaron Chevinsky, a surgical oncologist specializing in ... and has created a groundbreaking team approach to improve communication among ... ...
... Alternatives International, Inc. ("NAI") (Nasdaq: NAII ... customized nutritional supplements, today announced that effective December ... with NAI ended.NAI also announced it completed certain ... Bank. Among other changes the amendments extend ...
... Tenn., Jan. 7 Ambulatory Services of America,Inc. ... LLC, its seventh,radiation oncology joint venture. ROSA ... Coast Cancer Center - Gulf Shores, P.C., Monroeville ... P.C., and ASA,s,subsidiary, Radiation Oncology Services of America, ...
... Hanger Orthopedic Group, Inc. (NYSE: HGR ) ... operations for the year ended December 31, 2008, on Tuesday, ... announcing the results for the year ended December 31, 2008 ... market. The conference call is scheduled to begin at 9:00 ...
... low levels would work for ER patients with hypoxia ... Going to the world,s most elevated natural laboratory, Mount ... rules about the amount of oxygen needed by a ... can tolerate extremely low levels of oxygen, much lower ...
... 73 Percent Increase in Patients Unable to Pay Out-of-Pocket ... ERsSACRAMENTO, Calif., Jan. 7 The ... impact on California,s community hospitals, according to a newly ... The report, which is based on a survey conducted ...
Other Medicine News:Health News:Nationally-Recognized Pancreatic Cancer Surgeon Develops Unique Team Approach to Improve Patient Outcomes 2Health News:Natural Alternatives International, Inc. Announces Change in Executive Officer and Loan Modification and Extension 2Health News:Ambulatory Services of America, Inc. Announces Joint Venture with Gulf Coast Cancer Centers 2Health News:Hanger Orthopedic Group, Inc. Announces 2008 Year-End Earnings Release Conference Call 2Health News:Study of Everest Climbers Questions Oxygen Use 2Health News:Study of Everest Climbers Questions Oxygen Use 3Health News:Economic Downturn Takes Toll on California Hospitals 2
(Date:5/22/2012)... 2012  Today ZocDoc introduces its ... online access to appointments with Greater Denver,s leading ... At launch, this free service provides patients with ... participating primary care doctors, obstetrician-gynecologists, dermatologists and eye ... specialties, and appointment times will be added in ...
(Date:5/22/2012)... 22, 2012  Unigene Laboratories, Inc. (OTCBB: ... manufacture and development of peptide-based therapeutics today reported ... rats and dogs for its lead proprietary anorexigenic ... anorexigenic peptide selectively targeting the amylin receptor, is ... morbid obesity.  In multiple-dose pharmacology studies in rats ...
(Date:5/22/2012)... Conn., May 22, 2012   Valeritas , ... a new, simple disposable device for the delivery ... 2 diabetes, has selected dLife to ... number-one resource and community network for people living ... V-Go Life, a comprehensive diabetes lifestyle management and ...
Breaking Medicine Technology:Denver Patients Can Now Easily Find Doctors and Schedule Appointments Online 2Denver Patients Can Now Easily Find Doctors and Schedule Appointments Online 3Denver Patients Can Now Easily Find Doctors and Schedule Appointments Online 4Unigene's Potent, Anorexigenic Peptide, UGP281, Demonstrates Dramatic Dose Dependent Reductions in Food Intake with Subsequent Significant Body Weight Reduction in Preclinical Studies 2Unigene's Potent, Anorexigenic Peptide, UGP281, Demonstrates Dramatic Dose Dependent Reductions in Food Intake with Subsequent Significant Body Weight Reduction in Preclinical Studies 3Unigene's Potent, Anorexigenic Peptide, UGP281, Demonstrates Dramatic Dose Dependent Reductions in Food Intake with Subsequent Significant Body Weight Reduction in Preclinical Studies 4Unigene's Potent, Anorexigenic Peptide, UGP281, Demonstrates Dramatic Dose Dependent Reductions in Food Intake with Subsequent Significant Body Weight Reduction in Preclinical Studies 5Valeritas Inc. Selects dLife's New Diabetes Patient Engagement Solution For Valeritas' V-go Disposable Insulin Delivery Device 2Valeritas Inc. Selects dLife's New Diabetes Patient Engagement Solution For Valeritas' V-go Disposable Insulin Delivery Device 3Valeritas Inc. Selects dLife's New Diabetes Patient Engagement Solution For Valeritas' V-go Disposable Insulin Delivery Device 4Low Vitamin D Levels Linked to More Aggressive Breast Cancers 81455 1Low Vitamin D Levels Linked to More Aggressive Breast Cancers 81455 2Low Vitamin D Levels Linked to More Aggressive Breast Cancers 81455 3Researchers discover mechanism that could convert certain cells into insulin making cells 81453 1Researchers discover mechanism that could convert certain cells into insulin making cells 81453 2Dune Medicals MarginProbe u2122 Demonstrates Increased Positive Margin Identification Leading to Reduction in Patients Indicated for Re excision in La 19276 1Dune Medicals MarginProbe u2122 Demonstrates Increased Positive Margin Identification Leading to Reduction in Patients Indicated for Re excision in La 19276 2Dune Medicals MarginProbe u2122 Demonstrates Increased Positive Margin Identification Leading to Reduction in Patients Indicated for Re excision in La 19276 3Dune Medicals MarginProbe u2122 Demonstrates Increased Positive Margin Identification Leading to Reduction in Patients Indicated for Re excision in La 19276 4
... Trial Reconfirms Strong Evidence Pycnogenol(R) Lowers Joint, Pain, Symptoms; May Now ... ... of the Extract, HOBOKEN, N.J., Sept. 3 ... type of arthritis,is on the rise. A new study published in ...
... sub-analysis of,the TRITON-TIMI 38 clinical trial showed ... reduced the risk of new or,recurrent heart ... regardless,of whether the events occurred around the ... coronary intervention (PCI), or if they,occurred spontaneously ...
Other Medicine Technology:Study Shows Pine Bark Naturally Reduces Knee Osteoarthritis 2Study Shows Pine Bark Naturally Reduces Knee Osteoarthritis 3Study Shows Pine Bark Naturally Reduces Knee Osteoarthritis 4Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel 2Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel 3Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel 4Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel 5Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel 6
... ASP200 is an advanced smart processor for ... routine histopathology applications. Proven and enhanced technology ... operating software are the hallmark of the ... and the software includes a variety of ...
The HMP300 Histo Pro delivers all the features and benefits that conventional tissue processing have to offer....
... A totally new concept in a power ... and sliding microtomes. Power assisted horizontal movements ... moving across the knife edge. Duplicate controls ... or right hand while the operating levers ...
... and precision as well as outstanding ergonomic ... is an eclusive design feature of MICROM. ... retraction during return travel, quick trim feature ... section counter. With these microtome, MICROM sets ...
Medicine Products: